ANA Mª
GONZÁLEZ-PINTO ARRILLAGA
Hospital Universitario de Cruces
Barakaldo, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Cruces (18)
2024
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
2023
-
Psychosis and substance abuse increase the COVID-19 mortality risk
Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244
-
Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study
Epidemiology and psychiatric sciences, Vol. 32, pp. e50
2022
-
Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey
Epidemiology and Psychiatric Sciences, Vol. 31
2021
-
Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms
Frontiers in Psychiatry, Vol. 12
-
Gender-Based Analysis of the Psychological Impact of the COVID-19 Pandemic on Healthcare Workers in Spain
Frontiers in Psychiatry, Vol. 12
-
Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105
-
Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak
Depression and Anxiety, Vol. 38, Núm. 5, pp. 528-544
-
Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic
Epidemiology and Psychiatric Sciences, Vol. 30
2020
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
2019
-
A systematic review of sex-based differences in effectiveness and adverse effects of clozapine
Psychiatry Research, Vol. 280
2018
-
Smoking does not impact social and non-social cognition in patients with first episode psychosis
Schizophrenia Research, Vol. 199, pp. 64-74
-
Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment
Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267
2017
-
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656
2008
-
Curso del funcionamiento cognitivo en primeros episodios psicóticos: estudio comparativo entre esquizofrenia y otros diagnósticos psicóticos
Revista de Psiquiatria y Salud Mental, Vol. 1, Núm. 1, pp. 18-25
2002
-
Tratamiento precoz con risperidona de primeros episodios psicóticos: Dos años de seguimiento
Actas Espanolas de Psiquiatria, Vol. 30, Núm. 3, pp. 142-152
2000
-
Hospitalización contra la voluntad en primeros episodios psicóticos: Factores asociados
Actas Espanolas de Psiquiatria, Vol. 28, Núm. 5, pp. 275-278